Notogen

Notogen is biotechnology company developing regenerative therapeutics for conditions related to spinal degeneration, orthopedics and sports medicine.

[Notogen @NotogenInc]

Notogen is very pleased to announce that it has entered a worldwide research collaboration and license agreement with Boehringer Ingelheim to develop and commercialize a Notogen regenerative therapeutic for people living with degenerative disc disease.
https://t.co/OnH7Mdepfd

[Notogen @NotogenInc]

New CEO, Gary Margolis, believes NTG-101 "has the potential to be a game-changing treatment for disc degeneration disease.” https://t.co/nX7vY8lHtU

[Notogen @NotogenInc]

Notogen Appoints Gary Margolis as New Chief Executive Officer
https://t.co/5fmj0J8GmH

#biotech #regenerativemedicine #biologics #drugdevelopment #notogen #NTG101

[Notogen @NotogenInc]

"The findings are supportive of NTG-101 as a means to impede disc degeneration, promote disc regeneration, halt inflammation, and suppress the expression of molecules secreted by discs that are known causes of pain.” -Dr. Mark Erwin #biotech #regenerativemedicine

[Notogen @NotogenInc]

NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease https://t.co/tMHasP1xx0 @SciReports @UofT @UAlberta @UHN

[Notogen @NotogenInc]

Therapeutic Potential of NTG-101, a Single Dose Injectable Treatment for Degenerative Disc Disease, Demonstrated in Preclinical Large Animal Study Published in Nature Publishing Group's “Scientific Reports” https://t.co/HI1U6S1K5h @SciReports @NatureNews

[Notogen @NotogenInc]

We're pleased to announce the launch of our new website. Visit us at https://t.co/v2o83Ne6bB #biotech #startup #regenerativemedicine

[Notogen @NotogenInc]

W Mark Erwin, DC, PhD Biological Therapy for the Degenerative Disc: https://t.co/VTb78Uh3pF via @YouTube